DGAP-News: AGO AG publishes interim figures for first half

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-News: AGO AG publishes interim figures for first half of 2013

DGAP-News: AGO AG Energie + Anlagen / Key word(s): Half Year Results AGO AG publishes interim figures for first half of 2013 30.09.2013 / 18:08 --------------------------------------------------------------------- Corporate news from 30 September 2013 AGO AG publishes interim figures for first half of 2013 - Sales: EUR 20,674 thousand (previous year: 21,414) - Gross margin (adjusted): 9.1 percent - EBIT: EUR 386 thousand (+162.6 percent) - Outlook: Increase in average order margin and significant improvement to annual earnings in 2013 Kulmbach, 30 September 2013: AGO AG Energie + Anlagen (WKN: A0LR41, ISIN: DE000A0LR415) has published its interim results for the first half of 2013, a period characterised by the restructuring project initiated in 2012, in accordance with IFRS accounting principles. Against this backdrop, sales at AGO AG Energie + Anlagen fell in the first half of 2013 by EUR 740 thousand or 3.5 percent to EUR 20,674 thousand (previous year: EUR 21,414 thousand). Gross profit was down by EUR 210 thousand or 15 percent from EUR 1,395 thousand to EUR 1,185 thousand. As a result, the gross margin came to 5.7 percent (previous year: 6.5 percent). Adjusted for the costs of the wood gas power plant in Senden and the costs from Fittings GmbH Formstücke + Anlagen i.L., whose liquidation had already been concluded, the gross margin would have totalled 9.1 percent. EBITDA increased by EUR 352 thousand or 94.9 percent to EUR 723 thousand (previous year: EUR 371 thousand). A much more significant increase was seen in EBIT, which rose by EUR 239 thousand or 162.6 percent from EUR 147 thousand to EUR 386 thousand. Earnings from continued operations increased by EUR 246 thousand to EUR 38 thousand (previous year: EUR -208 thousand). Earnings from discontinued operations increased by EUR 853 thousand to EUR -701 thousand (previous year: EUR -1,554 thousand). This caused consolidated net profit for the period to increase by EUR 1,133 thousand from EUR -1,753 thousand to EUR -620 thousand. Accordingly, earnings per share (number of shares: 3,348,269) in the first half of 2013 came to EUR -0.19 (previous year: EUR -0.52). 'So far we have seen a substantial increase in our equity base in 2013,' says Georg-Stephan Wilkening, member of the Management Board of AGO AG Energie + Anlagen. 'As a result, the AGO AG balance sheet will see a reduction in total assets, because of a decrease in current interest-bearing liabilities, and an improvement in balance sheet ratios at the end of 2013. With an order backlog of EUR 24,920 thousand and incoming orders totalling EUR 17,177 thousand as of 30 June 2013, we are looking to the rest of the year with a great deal of optimism. We hope to boost the average order margin and anticipate a significant improvement to our earnings situation.' The AGO AG Energie + Anlagen interim report for the first half of 2013 will shortly be available for download at www.ago.ag under 'Investor Relations'. About AGO AG Energie + Anlagen: AGO AG Energie + Anlagen, with its registered office in Kulmbach, was founded in 1980 and is specialized in the area of innovative and efficient energy supply facilities for industrial customers and municipalities. Main focus of AGO AG Energie + Anlagen is laid on the following business divisions: plant development and implementation, as well as service and consulting. The core competence of the company mainly commits to thermal power stations, to heating, cooling and ventilation technology plant construction, biomass cogeneration plants, natural gas cogeneration and trigeneration. Site studies and development, consulting in energy efficiency as well as resource and fossil fuel management - these factors complete the business model. AGO symbolizes efficiency, security and technological competence of your energy supply facilities. Company contact: AGO AG Energie + Anlagen Am Goldenen Feld 23 D-95326 Kulmbach www.ago.ag T. +49 (0) 9221 602 0 F. +49 (0) 9221 602 149 ir-ago@ago.ag Investor Relations contact: GFEI Aktiengesellschaft Marcus Kapust Am Hauptbahnhof 6 60329 Frankfurt am Main www.gfei.de T. +49 (0) 69 743 037 00 F. +49 (0) 69 743 037 22 ir-ago@gfei.de End of Corporate News --------------------------------------------------------------------- 30.09.2013 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: AGO AG Energie + Anlagen Am Goldenen Feld 23 95326 Kulmbach Germany Phone: +49 (0)9221 602-0 Fax: +49 (0)9221 602-149 E-mail: info@ago.ag Internet: http://www.ago.ag ISIN: DE000A1TNL44 WKN: A1TNL4 Listed: Freiverkehr in Berlin, Düsseldorf, Stuttgart; Frankfurt in Open Market (Entry Standard) End of News DGAP News-Service --------------------------------------------------------------------- 232691 30.09.2013

Scroll down for more posts ▼

Top 10 Most Recent News Articles

NARUTO Card Game Set for June 2027 Global Launch

Updated Category News Views 14

Mark Your Calendars: Global Launch June 2027 They're rolling out a red carpet for nostalgia here, I tell ya! At the New York Comic Con, BANDAI announced a worldwide launch for the NARUTO CARD GAME in June 2027. We'll see pre-built decks starring your favorite shinobi and a mad sprint to collect with the new booster packs. Feels sort of like they’re summoning a jutsu...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 9

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 14

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 17

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 12

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 11

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 8

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 11

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 12

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading

Top 5 Most Recently Viewed Articles

Semtech Corporation Faces Legal Challenge: Shareholder Rights Explained

Updated Category News Views 145

Understanding the Current Legal Landscape for Semtech Corporation Semtech Corporation, a notable player in the semiconductor industry, is currently embroiled in a significant class action lawsuit concerning alleged violations of federal securities laws. This legal action has garnered the attention of investors and shareholders alike, prompting them to seek clarity on...

Continue Reading
Breezeline Expands Fiber Internet Access in New Hampshire

Updated Category News Views 194

Breezeline's Commitment to Fiber Internet Expansion Breezeline is actively enhancing its service offerings by deploying fiber-to-the-home internet in several communities across New Hampshire. This exciting initiative aims to connect towns such as Barnstead, Farmington, Franklin, Milton, Northfield, Pittsfield, Rochester, Tilton, and Wolfeboro with high-speed internet. As...

Continue Reading
Investigation into Cepton, Inc.'s Share Sale: What's Next for Investors?

Updated Category News Views 78

Cepton, Inc. (NASDAQ: CPTN) got itself tangled in a mess back when it sold to KOITO MANUFACTURING CO., LTD. for $3.17 per share. Traders were quick on the draw as Halper Sadeh LLC kicked off an investigation into whether that price was just or a complete rip-off for shareholders. The heart of the issue? Was Cepton’s board really looking out for their shareholders’...

Continue Reading
Affordable 5G Solutions for Low-Income Households Set to Transform Lives

Updated Category News Views 218

Mission Telecom Partners with Computers 4 People This innovative partnership is set to eliminate significant barriers to affordable broadband for low-income households. By dramatically reducing hardware costs, these organizations aim to transform internet access across communities. An Unprecedented Move Towards Digital Equity The collaboration between Mission Telecom and...

Continue Reading
KPN's Strategy and Progress on €250 Million Share Buyback

Updated Category News Views 139

KPN's Strategic Share Buyback Initiative KPN is making notable strides with its €250 million share buyback program. Recently, the company repurchased a significant amount of its ordinary shares from March 24 to March 28. This specific buyback involved 2,020,000 shares, purchased at an average price of €3.84 per share, totaling approximately €7.8 million. These...

Continue Reading